Healthcare provider profile · identity verified

Susan Morales, MD

Internal Medicine · NEW YORK, NY · NPI 1548357619

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	674	240
Amlodipine Besylate	Amlodipine Besylate	431	167
Losartan Potassium	Losartan Potassium	302	100
Albuterol Sulfate Hfa	Albuterol Sulfate	278	65
Metformin Hcl	Metformin Hcl	266	90
Lisinopril	Lisinopril	240	79
Rosuvastatin Calcium	Rosuvastatin Calcium	230	93
Metoprolol Succinate	Metoprolol Succinate	211	61
Omeprazole	Omeprazole	188	67
Levothyroxine Sodium	Levothyroxine Sodium	185	72
Metformin Hcl Er	Metformin Hcl	165	55
Fluticasone Propionate	Fluticasone Propionate	161	46
Gabapentin	Gabapentin	150	51
Hydrochlorothiazide	Hydrochlorothiazide	123	56
Famotidine	Famotidine	118	38
Montelukast Sodium	Montelukast Sodium	116	45
Eliquis	Apixaban	89	23
Simvastatin	Simvastatin	82	30
Diclofenac Sodium	Diclofenac Sodium	79	25
Escitalopram Oxalate	Escitalopram Oxalate	76	32
Carvedilol	Carvedilol	75	24
Nifedipine Er	Nifedipine	75	21
Jardiance	Empagliflozin	74	21
Furosemide	Furosemide	73	26
Ozempic	Semaglutide	72	25
Pantoprazole Sodium	Pantoprazole Sodium	71	27
Sertraline Hcl	Sertraline Hcl	62	24
Trazodone Hcl	Trazodone Hcl	59	24
Mirtazapine	Mirtazapine	58	23
Xarelto	Rivaroxaban	55	12
Clotrimazole	Clotrimazole	54	13
Ammonium Lactate	Ammonium Lactate	50	11
Hydrocortisone	Hydrocortisone	50	15
Tamsulosin Hcl	Tamsulosin Hcl	47	21
Atenolol	Atenolol	45	16
Meclizine Hcl	Meclizine Hcl	45	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	15
Naproxen	Naproxen	43	12
Duloxetine Hcl	Duloxetine Hcl	42	14
Januvia	Sitagliptin Phosphate	42	12
Loperamide	Loperamide Hcl	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	15
Hydralazine Hcl	Hydralazine Hcl	39	12
Ketoconazole	Ketoconazole	39	suppressed
Pregabalin	Pregabalin	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	17
Triamcinolone Acetonide	Triamcinolone Acetonide	38	12
Chlorthalidone	Chlorthalidone	37	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	37	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Spironolactone	Spironolactone	33	11
Baclofen	Baclofen	32	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Ezetimibe	Ezetimibe	32	15
Allopurinol	Allopurinol	30	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	29	12
Valacyclovir	Valacyclovir Hcl	29	suppressed
Azelastine Hcl	Azelastine Hcl	28	suppressed
Finasteride	Finasteride	28	13
Pravastatin Sodium	Pravastatin Sodium	28	13
Valsartan	Valsartan	28	11
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Arnuity Ellipta	Fluticasone Furoate	26	suppressed
Single Use Swab	Alcohol Antiseptic Pads	24	suppressed
Clonazepam	Clonazepam	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	12
Meloxicam	Meloxicam	22	suppressed
Rybelsus	Semaglutide	21	suppressed
Bupropion Hcl	Bupropion Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Torsemide	Torsemide	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Brilinta	Ticagrelor	18	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Restasis	Cyclosporine	17	suppressed
Topiramate	Topiramate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Azithromycin	Azithromycin	15	suppressed
Glipizide	Glipizide	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Nyamyc	Nystatin	12	suppressed
Prednisone	Prednisone	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Linzess	Linaclotide	11	suppressed
Methimazole	Methimazole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error